NFKB1 and chronic myelogenous leukemia, BCR-ABL1 positive: Furthermore, we reveal the critical function of a previously uncharacterized protein, FAM167A, in the noncanonical NF-κB pathway in CML with BCR-ABL-independent TKI resistance.